Order of the Vice-President of the Court of 26 February 2020 — Medac Gesellschaft für klinische Spezialpräparate v Commission
(Case C‑832/19 P(R))
(Appeal — Order for interim measures — Medicinal products for human use — Application for marketing authorisation for an orphan medicinal product —Commission decision to remove a medicinal product from the Register of Orphan Medicinal Products — Urgency — Serious and irreparable damage — None)
Appeal — Grounds — Incorrect assessment of the facts and evidence — Inadmissibility — Review by the Court of the General Court’s findings with regard to national law — Possible only where the clear sense of the evidence has been distorted
(Art. 256(1), second para., TFEU; Statue of the Court of Justice, Art. 58, first para.)
(see para. 40, 41)
Operative part
1. | | The appeal is dismisssed. |
2. | | Medac Gesellschaft für klinische Spezialpräparate mbH is ordered to pay the costs. |